Survey of Ophthalmology
Volume 49, Issue 4 , Pages 419-428 , July 2004

Sunlight exposure and pathogenesis of uveal melanoma

  • Arun D Singh, MD, FRCS, FRCOphth

      Affiliations

    • Corresponding Author InformationReprint address: Arun D. Singh, MD, Department of Ophthalmic Oncology, Cole Eye Institute (i3-129), Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195.
    • ,
  • Ian G Rennie, FRCS, FRCOphth

      Affiliations

    • ,
  • Stefan Seregard, MD

      Affiliations

    • ,
  • Michael Giblin, MD

      Affiliations

    • ,
  • John McKenzie, MD

      Affiliations

References 

  1. Abrahamsson M. Malignant melanoma of the choroid and the ciliary body 1956–1975 in Halland and Gothenburg. Incidence, histopathology and prognosis. Acta Ophthalmol (Copenh). 1983;61:600–610
  2. Ajani UA, Seddon JM, Hsieh CC, et al.  Occupation and risk of uveal melanoma. An exploratory study. Cancer. 1992;70:2891–2900
  3. Aoyagi M, Morishima N, Yoshino Y, et al.  Conjunctival malignant melanoma with xeroderma pigmentosum. Ophthalmologica. 1993;206:162–167
  4. Bergman L, Seregard S, Nilsson B, et al.  Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43:2579–2583
  5. Birdsell JM, Gunther BK, Boyd TA, et al.  Ocular melanoma: a population-based study. Can J Ophthalmol. 1980;15:9–12
  6. Biswas J, Krishnakumar S, Shanmugam MP. Uveal melanoma in Asian Indians: a clinicopathological study. Arch Ophthalmol. 2002;120:522–523
  7. Boettner EA, Woltner JR. Transmission of ocular media. Invest Ophthalmol. 1962;1:776–783
  8. Bulliard JL, Cox B, Elwood JM. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer. 1997;72:231–235
  9. Casswell AG, McCartney AC, Hungerford JL. Choroidal malignant melanoma in an albino. Br J Ophthalmol. 1989;73:840–845
  10. Davidorf FH, Knupp JA. Epidemiology of ocular melanoma. Incidence and geographic relationship in Ohio (1967–1977). Ohio State Med J. 1979;75:561–564
  11. Demunter A, Stas M, Degreef H. Analysis of n- and k-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol. 2001;117:1483–1489
  12. Dolin PJ, Foss AJ, Hungerford JL. Uveal melanoma: is solar ultraviolet radiation a risk factor?. Ophthalmic Epidemiol. 1994;1:27–30
  13. Egan KM, Seddon JM, Glynn RJ, et al.  Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239–251
  14. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer. 1997;73:198–203
  15. Freeman SE, Hacham H, Gange RW, et al.  Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA. 1989;86:5605–5609
  16. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22–33
  17. Gallagher RP, Elwood JM, Rootman J, et al.  Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst. 1985;74:775–778
  18. Ganley JP, Comstock GW. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol. 1973;76:19–25
  19. Geeraets WJ, Berry ER. Ocular spectral characteristics as related to hazards from lasers and other light sources. Am J Ophthalmol. 1968;66:15–20
  20. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341–1348
  21. Gı́slason I, Magnússon B, Tulinius H. Malignant melanoma of the uvea in Iceland 1955–1979. Acta Ophthalmol (Copenh). 1985;63:389–394
  22. Guénel P, Laforest L, Cyr D, et al.  Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control. 2001;12:451–459
  23. Hakulinen T, Teppo L, Saxén E. Cancer of the eye, a review of trends and differentials. World Health Stat Q. 1978;31:143–158
  24. Herlyn M, Satyamoorthy K. Activated ras. Yet another player in melanoma?. Am J Pathol. 1996;149:739–744
  25. Holly EA, Aston DA, Ahn DK, Smith AH. Intraocular melanoma linked to occupations and chemical exposures. Epidemiology. 1996;7:55–61
  26. Holly EA, Aston DA, Char DH, et al.  Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res. 1990;50:5773–5777
  27. Ihn H, Nakamura K, Abe M, et al.  Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. J Am Acad Dermatol. 1993;28:895–900
  28. Imesch PD, Bindley CD, Khademian Z, et al.  Melanocytes and iris color. Electron microscopic findings. Arch Ophthalmol. 1996;114:443–447
  29. Imesch PD, Wallow IH, Albert DM. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. Surv Ophthalmol. 1997;41(Suppl 2):S117–S123
  30. Iscovich J, Abdulrazik M, Pe'Er J. Posterior uveal malignant melanoma: temporal stability and ethnic variation in rates in Israel. Anticancer Res. 2001;21:1449–1454
  31. Iscovich J, Ackerman C, Andreev H, et al.  An epidemiological study of posterior uveal melanoma in Israel, 1961–1989. Int J Cancer. 1995;61:291–295
  32. Jensen O. Malignant melanomas of the uvea in Denmark 1943–1952. Acta Ophthalmol. 1963;75:17–78
  33. Jensen OA. Malignant melanoma of the iris. A 25-year analysis of Danish cases. Eur J Ophthalmol. 1993;3:181–188
  34. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol. 1998;111:757–761
  35. Johnson MW, Skuta GL, Kincaid MC, et al.  Malignant melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol. 1989;107:402–407
  36. Kaneko A. [Malignant ophthalmic tumors]. Nippon Rinsho. 1993;51(Suppl):1013–1020
  37. Kheterpal S, Shields JA, Shields CL, et al.  Choroidal melanoma in an African-American albino. Am J Ophthalmol. 1996;122:901–903
  38. Kliman GH, Augsburger JJ, Shields JA. Association between iris color and iris melanocytic lesions. Am J Ophthalmol. 1985;100:547–548
  39. Kobayashi N, Nakagawa A, Muramatsu T, et al.  Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol. 1998;110:806–810
  40. Kocabalkan O, Ozgür F, Erk Y, et al.  Malignant melanoma in xeroderma pigmentosum patients: report of five cases. Eur J Surg Oncol. 1997;23:43–47
  41. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241–250
  42. Kuo PK, Puliafito CA, Wang KM, et al.  Uveal melanoma in China. Int Ophthalmol Clin. 1982;22:57–71
  43. Lerman S. Radiant energy and the eye. New York: Macmillan Publishing Co., Inc; 1980; pp 2–3
  44. Lerman S. Radiant energy and the eye. New York: Macmillan Publishing Co., Inc; 1980; pp 58
  45. Lerman S. Radiant energy and the eye. New York: Macmillan Publishing Co., Inc; 1980; pp 88
  46. Li W, Judge H, Gragoudas ES, et al.  Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000;60:3757–3760
  47. Lommatzsch PK, Staneczek W, Bernt H. [Epidemiologic study of new cases of intraocular tumors in East Germany 1961–1980]. Klin Monatsbl Augenheilkd. 1985;187:487–492
  48. Margo CE, Mulla Z, Billiris K. Incidence of surgically treated uveal melanoma by race and ethnicity. Ophthalmology. 1998;105:1087–1090
  49. McKenzie R, Connor B, Bodeker G. Increased summertime UV radiation in New Zealand in response to ozone loss. Science. 1999;285:1709–1711
  50. Menon IA, Wakeham DC, Persad SD, et al.  Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J Ocul Pharmacol. 1992;8:35–42
  51. Michalova K, Clemett R, Dempster A, et al.  Iris melanomas: are they more frequent in New Zealand?. Br J Ophthalmol. 2001;85:4–5
  52. Mitchell DL, Jen J, Cleaver JE. Relative induction of cyclobutane dimers and cytosine photohydrates in DNA irradiated in vitro and in vivo with ultraviolet-C and ultraviolet-B light. Photochem Photobiol. 1991;54:741–746
  53. Mooy CM, Van der Helm MJ, Van der Kwast TH, et al.  No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited. Br J Cancer. 1991;64:411–413
  54. Mork T. Malignant melanoma of the eye in Norway: incidence, treatment and prognosis. Acta Ophthalmol. 1961;39:824–831
  55. Ortonne JP. Photobiology and genetics of malignant melanoma. Br J Dermatol. 2002;61(Suppl):11–16
  56. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes. Am J Ophthalmol. 1996;121:181–189
  57. Pane AR, Hirst LW. Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia. Ophthalmic Epidemiol. 2000;7:159–167
  58. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5–27
  59. In:  Parkin DM,  Muir CS,  Whelan SL, et al. editor. Cancer incidence in five continents. Lyon, France: International Agency for Research on Cancer; 1992;
  60. Peyman GA, Raichand M, Zeimer RC. Ocular effects of various laser wavelengths. Surv Ophthalmol. 1984;28:391–404
  61. Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984. Cancer. 1993;71:1893–1897
  62. Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol. 1977;133(Suppl):1–64
  63. Remé C, Reinboth J, Clausen M, Hafezi F. Light damage revisited: converging evidence, diverging views?. Graefes Arch Clin Exp Ophthalmol. 1996;234:2–11
  64. Riley PA. Melanin. Int J Biochem Cell Biol. 1997;29:1235–1239
  65. Rootman J, Gallagher RP. Color as a risk factor in iris melanoma. Am J Ophthalmol. 1984;98:558–561
  66. Rosenthal FS, Bakalian AE, Lou CQ, Taylor HR. The effect of sunglasses on ocular exposure to ultraviolet radiation. Am J Public Health. 1988;78:72–74
  67. Rosenthal FS, Bakalian AE, Taylor HR. The effect of prescription eyewear on ocular exposure to ultraviolet radiation. Am J Public Health. 1986;76:1216–1220
  68. Rosenthal FS, Phoon C, Bakalian AE, Taylor HR. The ocular dose of ultraviolet radiation to outdoor workers. Invest Ophthalmol Vis Sci. 1988;29:649–656
  69. Rosenthal FS, West SK, Munoz B, et al.  Ocular and facial skin exposure to ultraviolet radiation in sunlight: a personal exposure model with application to a worker population. Health Phys. 1991;61:77–86
  70. Rosner B. Fundamentals of biostatistics. Belmont, CA: Wadsworth Publishing Company; 1995; pp 367–70
  71. Sackett DL, Straus S, Richardson WS, et al.  Evidence-based medicine. How to practice and teach EBM. Edinburgh: Churchill Livingstone; 2000;
  72. Schwartz LH, Ferrand R, Boelle PY, et al.  Lack of correlation between the location of choroidal melanoma and ultraviolet-radiation dose distribution. Radiat Res. 1997;147:451–456
  73. Schwartz SM, Weiss NS. Place of birth and incidence of ocular melanoma in the United States. Int J Cancer. 1988;41:174–177
  74. Scotto J, Fraumeni JF, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst. 1976;56:489–491
  75. Seddon JM, Gragoudas ES, Glynn RJ, et al.  Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990;108:1274–1280
  76. Shammas HF, Watzke RC. Bilateral choroidal melanomas. Case report and incidence. Arch Ophthalmol. 1977;95:617–623
  77. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology. 2003;110:956–961
  78. Singh AD, Wang MX, Donoso LA, et al.  Genetic aspects of uveal melanoma: a brief review. Semin Oncol. 1996;23:768–772
  79. Sliney DH. Epidemiological studies of sunlight and cataract: the critical factor of ultraviolet exposure geometry. Ophthalmic Epidemiol. 1994;1:107–119
  80. Strickland D, Lee JA. Melanomas of eye: stability of rates. Am J Epidemiol. 1981;113:700–702
  81. Swerdlow AJ. Epidemiology of eye cancer in adults in England and Wales, 196–1977. Am J Epidemiol. 1983;118:294–300
  82. Swerdlow AJ. Epidemiology of melanoma of the eye in the Oxford Region, 1952–78. Br J Cancer. 1983;47:311–313
  83. Teikari JM, Raivio I. Incidence of choroidal malignant melanoma in Finland in the years 1973–1980. Acta Ophthalmol (Copenh). 1985;63:661–665
  84. Tenkate TD, Collins MJ. Personal ultraviolet radiation exposure of workers in a welding environment. Am Ind Hyg Assoc J. 1997;58:33–38
  85. Tucker MA, Shields JA, Hartge P, et al.  Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med. 1985;313:789–792
  86. Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43:3399–3408
  87. Vågerö D, Swerdlow AJ, Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med. 1990;47:317–324
  88. Vajdic CM, Kricker A, Giblin M, et al.  Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer. 2003;105:117–122
  89. Vajdic CM, Kricker A, Giblin M, et al.  Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer. 2002;101:175–182
  90. Vidal JL, Bacin F, Albuisson E, et al.  [“Melanoma 92”. Epidemiological study of uveal melanoma in France]. J Fr Ophtalmol. 1995;18:520–528
  91. Wang SQ, Setlow R, Berwick M, et al.  Ultraviolet A and melanoma: a review. J Am Acad Dermatol. 2001;44:837–846
  92. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12:69–82
  93. Wilkerson CL, Syed NA, Fisher MR, et al.  Melanocytes and iris color. Light microscopic findings. Arch Ophthalmol. 1996;114:437–442
  94. Wilkes S, Kurland L, Campbell RJ, Robertson DM. Incidence of uveal malignant melanoma. Am J Ophthalmol. 1979;88:629–630
  95. Zigman S. Lens UVA photobiology. J Ocul Pharmacol Ther. 2000;16:161–165
  96. Zigman S. Effects of near ultraviolet radiation on the lens and retina. Doc Ophthalmol. 1983;55:375–391

☆ The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article

PII: S0039-6257(04)00089-X

doi: 10.1016/j.survophthal.2004.04.009

Survey of Ophthalmology
Volume 49, Issue 4 , Pages 419-428 , July 2004

Article Tools

* Image Usage & Resolution